Competing interests
PVS
AMK has received personal consulting and/or speaking fees from AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, Sandoz, Roche, and UCB. SCR has received grants for clinical studies from AbbVie, Bristol-Myers Squibb, and Lilly and speaker fees from AbbVie, Amgen, Janssen, Pfizer, and UCB. MDB has received medical fees as a Clinical Investigator from AbbVie, Galapagos, and GlaxoSmithKline. FCIP has received speaker fees from AbbVie, Pfizer, Bristol-Myers Squibb, and Janssen; consulting fees from AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, and Pfizer; and medical fees as a Principal Investigator from AbbVie, Bristol-Myers Squibb, Celgene, Janssen, Pfizer, and Roche. CGG has received medical fees as a Principal Investigator from AbbVie. MSA, MC, JL, and MQ are employees of AbbVie and may own stock or options. PVS has received medical fees as a Principal Investigator from AbbVie. JIV has received medical fees as a Principal Investigator from AbbVie.